Metraipolis › archive › dc_560ff53750e6
Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42470061
- DOI
- 10.1097/md.0000000000049845
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:27:35.818Z
- SHA-256 of the archived text
bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8- Stable URL of this page
https://metraipolis.com/documento/dc_560ff53750e6
How to cite
Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061 — Europe PMC (en), https://europepmc.org/article/MED/42470061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_560ff53750e6 (Metraipolis archive dc_560ff53750e6, sha256 bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8)
BibTeX
@misc{dc560ff53750e6,
title = {Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42470061},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_560ff53750e6; sha256 bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42470061. Agents can read the archived copy with the MCP tool read_document.